Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI and CT Simulation in Esophageal Cancer Chemoradiotherapy
NCT02988921Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2016
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoints: Tumor response based on MRI and CT simulation up to 8 weeks, Radiotherapy target volume assessment up to 8 weeks and 1 more. Started Oct 2016; status: recruiting.
Beyond the preview
Go deeper on NCT02988921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02988921.